Takeda and TiGenix secure EU approval for stem cell therapy – Zenopa
|
Takeda and TiGenix secure EU approval for stem cell therapy
Zenopa Takeda and TiGenix have had their allogeneic stem cell therapy Alofisel approved for use by the EU, the first of its kind to be licensed in the 28-nation bloc. Previously known as Cx601, the therapy is designed to aid milder and non-active forms of … |
